Citadel Advisors
CLBT icon

Citadel Advisors’s Cellebrite CLBT Stock Holding History

Citadel Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.55M Sell
517,144
-919,057
-64% -$12.1M ﹤0.01% 4032
2026
Q1 		$19.8M Buy
1,436,201
+912,442
+174% +$13.8M ﹤0.01% 2357
2025
Q4 		$9.44M Buy
523,759
+33,547
+7% +$602K ﹤0.01% 3324
2025
Q3 		$9.08M Buy
490,212
+229,503
+88% +$3.61M ﹤0.01% 3417
2025
Q2 		$4.17M Sell
260,709
-20,309
-7% -$362K ﹤0.01% 4421
2025
Q1 		$5.46M Sell
281,018
-343,461
-55% -$7.23M ﹤0.01% 3727
2024
Q4 		$13.8M Sell
624,479
-219,174
-26% -$4.22M ﹤0.01% 2580
2024
Q3 		$14.2M Buy
843,653
+319,674
+61% +$4.74M ﹤0.01% 2445
2024
Q2 		$6.26M Sell
523,979
-178,683
-25% -$2M ﹤0.01% 3407
2024
Q1 		$7.79M Buy
702,662
+185,764
+36% +$1.9M ﹤0.01% 3287
2023
Q4 		$4.48M Buy
516,898
+329,109
+175% +$2.56M ﹤0.01% 3954
2023
Q3 		$1.44M Sell
187,789
-14,518
-7% -$109K ﹤0.01% 5854
2023
Q2 		$1.46M Buy
202,307
+54,361
+37% +$317K ﹤0.01% 5727
2023
Q1 		$901K Buy
147,946
+56,216
+61% +$305K ﹤0.01% 7007
2022
Q4 		$400K Sell
91,730
-32,076
-26% -$143K ﹤0.01% 8717
2022
Q3 		$486K Sell
123,806
-42,956
-26% -$215K ﹤0.01% 8512
2022
Q2 		$850K Sell
166,762
-3,491
-2% -$18.2K ﹤0.01% 7400
2022
Q1 		$1.09M Buy
170,253
+142,863
+522% +$947K ﹤0.01% 7500
2021
Q4 		$220K Buy
27,390
+6,470
+31% +$60.9K ﹤0.01% 11642
2021
Q3 		$194K Buy
+20,920
New +$219K ﹤0.01% 12027

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Citadel Advisors's CLBT Position: Q2 2026 in Review

Citadel Advisors reduced its Cellebrite (CLBT) stake by 64% in Q2 2026, selling an estimated $12.1M and leaving 517,144 shares worth $7.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4032.

Citadel Advisors first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $19.8M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Citadel Advisors held 517,144 shares of Cellebrite worth $7.55M as of Q2 2026.
  • Citadel Advisors sold 919,057 Cellebrite shares in Q2 2026, an estimated $12.1M.
  • Cellebrite made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4032 holding.
  • Citadel Advisors first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Cellebrite position peaked at $19.8M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.